Saudi Arabia is building the regulatory framework, partnerships infrastructure and IP landscape needed to support a biotech ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio.

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series ...

From advances in agricultural science and sustainable bioenergy to medical breakthroughs to new automated technologies, ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The current milk shortage in Kenya is a warning that a country with a large dairy economy can still leave farmers and consumers exposed when animal feed is scarce, costly and vulnerable to drought, ...

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.